论文部分内容阅读
国家中医药管理局最近制定了中成药工业国有重点企业50强行动计划,对进入50强的企业予以重点联系与服务。通过扶持建设好中成药工业国有重点企业,带动全行业发展。 有关人士指出,目前全国范围内纳入国家中医药管理局统计系统的中成药企业共有1020家,其中小型企业863家,占84.6％,系统内亏损企业中89％为小型企业。企业散、小、乱、低水平重复建设现象严重,中成药工业生产集中度水平低。形成一批代表行业水平,集约化、规模化程度高,占有较大市场份额,能够进入国际市场竞争的大型企业集团和企业,对于引导和促进中成药工业生产现代化将起到十分重要的促进作用。
The State Administration of Traditional Chinese Medicine recently formulated the top 50 state-owned key enterprises in the Chinese patent pharmaceutical industry to provide key contacts and services to the top 50 enterprises. By supporting the construction of state-owned key enterprises in the Chinese patent medicine industry, the entire industry will be driven. Relevant persons pointed out that there are currently 1,020 Chinese patent medicine companies that have been included in the statistical system of the State Administration of Traditional Chinese Medicine nationwide, of which 863 are small enterprises, accounting for 84.6%, and 89% of the loss-making enterprises in the system are small enterprises. The phenomenon of scattered, small, chaotic and low-level repeated construction of enterprises is serious, and the level of production concentration of the Chinese patent medicine industry is low. The formation of a number of large enterprise groups and enterprises that represent the industry level, intensification, large-scale, large market share, and can enter the international market competition will play a very important role in promoting and promoting the modernization of the Chinese patent pharmaceutical industry. .